In this episode of the Palo Alto Networks podcast 'Threat Vector,' host David Molton speaks with Jim Foote, CEO of First Ascent Biomedical about his transition from Chief Information Security Officer (CISO) to leading a biotech company utilizing AI to personalize cancer treatments. They discuss how Foote's personal experience with his son's cancer diagnosis drove him to apply cybersecurity principles in developing an innovative approach, called Functional Precision Medicine, which tailors cancer treatment to individual patients. The conversation also covers the role of mentorship, the importance of interdisciplinary skills, and the transformative potential of AI in both cybersecurity and medical fields. Join the conversation on our social media channels: Website: ⁠⁠⁠⁠https://www.paloaltonetworks.com/ Threat Research: ⁠⁠⁠⁠https://unit42.paloaltonetworks.com/⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠https://www.facebook.com/LifeatPaloAltoNetworks/⁠⁠⁠⁠ LinkedIn: ⁠⁠⁠⁠https://www.linkedin.com/company/unit42/⁠⁠⁠⁠ YouTube: @paloaltonetworks Twitter: ⁠⁠⁠⁠https://twitter.com/PaloAltoNtwks⁠⁠⁠⁠ About Threat Vector Threat Vector by Palo Alto Networks is your premier podcast for security thought leadership. Join us as we explore pressing cybersecurity threats, robust protection strategies, and the latest industry trends. The podcast features in-depth discussions with industry leaders, Palo Alto Networks experts, and customers, providing crucial insights for security decision-makers. Whether you're looking to stay ahead of the curve with innovative solutions or understand the evolving cybersecurity landscape, Threat Vector equips you with the knowledge needed to safeguard your organization. Palo Alto Networks Palo Alto Networks enables your team to prevent successful cyberattacks with an automated approach that delivers consistent security across the cloud, network, and mobile. ⁠http://paloaltonetworks.com⁠

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related